Quality Improvement in Neurology Multiple Sclerosis Quality Measurement Set 2020 Update

Multiple sclerosis (MS) is a disabling immune-mediated disease of the CNS and considered one of the health conditions with the highest annual spending growth paid by both public and private insurance.(1) Health care spending in the United States for MS was reported as $13.9 billion in 2016.(1) The estimated cumulated (over 10 years) prevalence of MS among adults in the United States in 2010 was approximately 727,000.(2) In 2017, that number was substantially higher, approximately 914,000.(2,3) The prevalence is higher among women, with a female: male ratio of 2.8.(2) Improving high-quality care for these patients can lead to improved outcomes, reduced spending, and better quality of life.

Automated summary

Multiple sclerosis is a disabling disease of the CNS with high prevalence in the United States, especially among women. Providing high-quality care can lead to improved outcomes, reduced spending, and better quality of life.